title: NICE guidance on nintedanib for previously treated locally advanced, metastatic, or locally recurrent non-small-cell lung cancer.
authors.affiliation: National Institute for Health and Care Excellence, Spring Gardens, London SW1A 2BU, UK. Electronic address: caroline.hall@nice.org.uk.
authors.forename: Caroline J
authors.initials: CJ
authors.lastname: Hall
authors.affiliation: National Institute for Health and Care Excellence, Spring Gardens, London SW1A 2BU, UK.
authors.forename: Nicola
authors.initials: N
authors.lastname: Hay
authors.affiliation: National Institute for Health and Care Excellence, Spring Gardens, London SW1A 2BU, UK.
authors.forename: Elisabeth
authors.initials: E
authors.lastname: George
authors.affiliation: National Institute for Health and Care Excellence, Spring Gardens, London SW1A 2BU, UK.
authors.forename: Amanda I
authors.initials: AI
authors.lastname: Adler
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local / Q000473:pathology / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D006113:United Kingdom
chemical_list: D007211:Indoles; C530716:nintedanib